Who owns CELLECTAR BIOSCIENCES INC?
- Ticker: CLRB
- CUSIP Number: 15117f880
Tip: Access positions for across all investors
Analyze quarterly positions in Cellectar Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cellectar Biosciences stock
Who bought or sold CELLECTAR BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bleichroeder | 100k | $295k | 0% | Dec 2025 |
|
| Vanguard Group | 89k | $263k | 37% | Dec 2025 |
|
| Vanguard Capital Management | 82k | $208k | 100% | Mar 2026 |
|
| Geode Capital Management | 53k | $134k | 84% | Mar 2026 |
|
| Sequoia Financial Advisors | 19k | $48k | -26% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 17k | $42k | 100% | Mar 2026 |
|
| Warberg Asset Management | 14k | $35k | 0% | Mar 2026 |
|
| XTX Topco | 12k | $36k | 100% | Dec 2025 |
|
| Susquehanna International | 12k | $36k | 100% | Dec 2025 |
|
| Riverview Capital Advisers | 10k | $50k | 0% | Mar 2026 |
|
| UBS Group | 9.6k | $25k | 271% | Mar 2026 |
|
| BlackRock | 4.7k | $12k | 0% | Mar 2026 |
|
| Tower Research Capital | 1.8k | $5.4k | 68% | Dec 2025 |
|
| Vanguard Global Advisers | 563.00 | $1.4k | 100% | Mar 2026 |
|
| Morgan Stanley | 510.00 | $1.3k | 0% | Mar 2026 |
|
| TD Waterhouse Canada | 63.00 | $153.997200 | 0% | Mar 2026 |
|
| SBI Securities | 11.00 | $28.000500 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 7.00 | $19.000100 | -70% | Dec 2025 |
|
| Jones Financial Companies, L.L | 3.00 | $9.000000 | 0% | Dec 2025 |
|
| Us Bancorp | 3.00 | $9.000000 | 0% | Dec 2025 |
|
| Danske Bank A/s | 2.00 | $5.000000 | 0% | Mar 2026 |
|
Who sold out of Cellectar Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 45k | $133k |
| Renaissance Technologies | Sep 2025 | 25k | $139k |